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Edited by Wolfgang PetiETV6 is an E26 transformation specific family transcrip-
tional repressor that self-associates by its PNT domain to
facilitate cooperative DNA binding. Chromosomal trans-
locations frequently generate constitutively active oncoproteins
with the ETV6 PNT domain fused to the kinase domain of one
of many protein tyrosine kinases. Although an attractive target
for therapeutic intervention, the propensity of the ETV6 PNT
domain to polymerize via the tight head-to-tail association of
two relatively flat interfaces makes it challenging to identify
suitable small molecule inhibitors of this protein–protein
interaction. Herein, we provide a comprehensive biophysical
characterization of the ETV6 PNT domain interaction in-
terfaces to aid future drug discovery efforts and help define the
mechanisms by which its self-association mediates transcrip-
tional repression. Using NMR spectroscopy, X-ray crystallog-
raphy, and molecular dynamics simulations, along with amide
hydrogen exchange measurements, we demonstrate that
monomeric PNT domain variants adopt very stable helical
bundle folds that do not change in conformation upon self-
association into heterodimer models of the ETV6 polymer.
Surface plasmon resonance–monitored alanine scanning
mutagenesis studies identified hot spot regions within the self-
association interfaces. These regions include both central hy-
drophobic residues and flanking salt-bridging residues.
Collectively, these studies indicate that small molecules tar-
geted to these hydrophobic or charged regions within the
relatively rigid interfaces could potentially serve as orthosteric
inhibitors of ETV6 PNT domain polymerization.
ETV6 is a modular transcriptional repressor of the ETS (E26
transformation specific) family for which head-to-tail poly-
merization of its PNT (or SAM) domain facilitates cooperative
binding to tandem DNA sites by its ETS domain (1, 2). The
defining DNA-binding ETS domain is conserved among all
ETS transcription factors, whereas the PNT domain is present
in approximately one-third of ETS paralogs (3). Unlike the
monomeric PNT domains of most ETS factors, the ETV6 PNTThis article contains supporting information.
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© 2021 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for
BY license (http://creativecommons.org/licenses/by/4.0/).domain self-associates in a head-to-tail fashion to form an
open-ended, left-handed helical polymer (4, 5). The only other
known self-associating PNT domains in the ETS family are
those of Drosophila Yan (6) and possibly human ETV7 (7–9),
as other PNT domains lack suitable interfaces because of
amino acid differences or steric blockage (10).
ETV6 is biologically important in embryonic development
and hematopoietic regulation (11, 12). Although reported to
recruit corepressors such as mSin3A, SMRT, and N-CoR (13),
the mechanisms by which ETV6 regulates transcription
require further investigation. Polymeric DNA-bound ETV6 is
proposed to cause localized chromatin compaction to block
access of the transcriptional machinery to target genes. This
speculative model is based on the observation that the repeat
distance of the helical polymer formed by the PNT domain is
comparable to the width of the nucleosome core particle (13).
ETV6 also has preeminent roles in cancer. Frequently,
chromosomal translocations fuse gene fragments encoding the
PNT domain of ETV6 with the kinase domain of one of many
diverse receptor protein tyrosine kinases (PTKs) or to the
DNA-binding domain from one of several transcription factors
(14). Known receptor PTK fusion partners of ETV6 include
PDGFβ, JAK2, FGFR3, and NTRK3. The resulting constitu-
tively active self-associated oncoproteins have been linked to
over 40 human leukemias, as well as fibrosarcomas, breast
carcinomas, and nephromas (14–16).
Owing to its presence in numerous fusion oncoproteins, the
ETV6 PNT domain is an attractive target for therapeutic
intervention (15). However, its propensity to form long
insoluble polymers via the tight head-to-tail association (KD 
nM) of two relatively flat interfaces (13) hinders identification
of suitable small molecule inhibitors (17). These interfaces,
termed the ML- and EH-surfaces (mid-loop and end-helix,
respectively), lie roughly on opposite sides on the globular
PNT domain (Fig. S1). Each is composed of a hydrophobic
patch encompassed by polar and charged side chains. The
introduction of an ionizable residue into either hydrophobic
patch yields a monomeric PNT domain as judged by several
techniques including equilibrium ultracentrifugation and
native gel electrophoresis (10, 13). Examples include the
V112E or V112R mutations that disrupt the EH-surface or theJ. Biol. Chem. (2021) 296 100284 1
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Characterizing the ETV6 PNT domainA93D mutation that disrupts the ML-surface. Two such
mutant PNT domains with complementary wild-type
interfaces can still form a heterodimer. The availability of
these monomeric and heterodimeric forms of the PNT domain
facilitates studies of ETV6 self-association.
In the case of the ETV6-NTRK3 (EN) fusion oncoprotein,
the introduction of monomerizing mutations blocked the
ability of EN to polymerize, to activate its PTK, and to trans-
form NIH3T3 cells (18). Furthermore, when co-expressed, the
isolated PNT domain had a dominant-negative effect on EN-
transformed cells (18). Subsequent studies showed that
weakening polymerization by disrupting a peripheral inter-
molecular salt bridge (K99-D101) also abrogated the ability of
EN to transform NIH 3T3 cells (19). Collectively, these studies
demonstrated that inhibiting PNT domain polymerization is
indeed a viable therapeutic strategy against ETV6-driven
cancers.
Understanding the mechanisms of PNT domain polymeri-
zation will yield insights in the transcriptional repression
properties of ETV6 and the oncogenic properties of ETV6
fusions. In particular, defining structural and thermodynamic
differences between monomeric and heterodimeric forms of
the PNT domain and determining “hot spot” regions for self-
association are both important for delineating the mecha-
nisms underlying polymerization and for developing strategies
to inhibit this process. Herein, using NMR spectroscopy, X-ray
crystallography, and molecular dynamics (MD) simulations,
we demonstrate that the structures of monomeric ETV6 PNT
domain variants do not change significantly upon mutation or
self-association into heterodimers. Amide hydrogen exchange
(HX) measurements confirmed that the monomeric PNT
domain is very stable in solution. Protection against exchange
increased upon heterodimerization for amides clustering near
the self-association interfaces. Complementary alanine scan-
ning mutagenesis revealed several hot spot regions within
these ML- and EH-surfaces. These residues partake in both
hydrophobic and electrostatic interactions and can serve as
starting points for targeted rational drug design.Results
PNT domain dimerization characterized by NMR spectroscopy
The NMR spectroscopy can give insights into the thermo-
dynamic, kinetic, and structural mechanisms of protein–ligand
interactions. A particularly convenient approach is to use 15N-
heteronuclear single quantum coherence (HSQC) spectra to
monitor the titration of a 15N-labeled protein with an unla-
beled, and hence NMR silent, ligand such as another protein
(20). Amide chemical shifts are highly sensitive to even subtle
environmental changes, and thus an interaction with the un-
labeled species can usually be detected through chemical shift
perturbations (CSPs) of the labeled protein. Amides exhibiting
CSPs typically cluster around the protein–ligand interface, yet
may also be distal if binding causes longer range (allosteric)
structural changes (20).
To begin this interrogation, purified samples of uniformly
13C/15N-labeled ETV6 fragments (residues 40–125; Table S1)2 J. Biol. Chem. (2021) 296 100284that contain either an A93D mutation or V112E mutation
(henceforth described as the A93D-PNT or V112E-PNT do-
mains, respectively) were prepared for NMR spectroscopic
characterization. Under neutral pH solution conditions, the
A93D-PNT and V112E-PNT domains yielded well-dispersed
NMR spectra indicative of stably folded structures (Fig. 1A).
However, the latter showed some propensity to self-associate,
and improved spectra were obtained at a sample pH value of
8.0. Presumably, this reflects the deprotonation of E112, which
may have an anomalously high pKa value when buried at the
polymer interface (21, 22). Unfortunately, the more alkaline
conditions resulted in some loss of signal intensity because of
base-catalyzed HX.
Upon addition of the unlabeled V112E-PNT domain to the
15N-labeled A93D-PNT domain, many amides exhibited CSPs
in the slow exchange regime (Figs. 1B and S2). That is, at an
intermediate titration point, separate 1HN-15N peaks corre-
sponding to the unbound (monomeric) and bound (hetero-
dimeric) forms of the labeled protein were observed. This is
consistent with the previously reported KD value of 2 nM for
the high-affinity binding equilibrium (13). Comparable results
were observed for the reciprocal titration of the unlabeled
A93D-PNT domain to the 15N-labeled V112E-PNT domain
(Fig. 1B). Although the oligomerization states of the PNT do-
mains in these experiments were not directly determined, the
results are entirely consistentwith previous studies showing that
the A93D-PNT and V112E-PNT domains aremonomeric when
separated and heterodimeric when combined (13).
Through a combination of scalar and NOE correlation ex-
periments, NMR signals were assigned from most main chain
1H, 13C, and 15N nuclei of the V112E-PNT and A93D-PNT
domains in their monomeric forms and as heterodimers with
their unlabeled partners (Figs. S3–S6). Utilizing the motif
identification from chemical shift algorithm (23), the second-
ary structural elements for the four species were predicted
from these chemical shifts. In each case, four distinct helical
regions were detected (Fig. 1C). These coincide well with the
four α-helices (H1: R63-E76; H2: G91-L94; H3: K99-R105; H4:
G110-K122) identified in the X-ray crystal structures of the
self-associated ETV6 PNT domains (PDB: 1JI7 and 1LKY) by
PDBsum (24). Matching two short N-terminal 310-helices
observed in these crystal structures, residues A52-L54 and, to a
lesser extent, P58-Y60 also have chemical shifts indicative of
helical character. In contrast, such diagnostic chemical shifts
were not seen for residues S84-T86 even though they are
classified as a forming a 310-helix in a subset of the monomer
subunits of PDB file 1LKY. This minor discrepancy may arise
because these residues are within an extended, solvent exposed
polypeptide segment between helices H1 and H2. Amides in
this region have chemical shift-derived random coil index-
squared order parameter values (RCI-S2, a proxy for back-
bone dynamics (25)) indicative of increased flexibility relative
to the well-ordered helices (Fig. 1C). Most importantly, these
analyses demonstrated that the A93D-PNT and V112E-PNT
domains have very similar secondary structures in their
monomeric and heterodimeric forms. Thus, the proteins in
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Figure 1. The PNT domains adopt stable folded structures in their monomeric and heterodimeric states. The 15N-HSQC spectra of the 15N-labeled
A93D-PNT domain (left) and V112E-PNT domain (right) in the absence (A) and presence (B) of unlabeled partner PNT domain. Assignments and sample
conditions are provided in Figures S3–S6. Apparent differences in 15N-HSQC linewidths result from the use of different conditions, spectral acquisition
parameters, and contour display parameters. C, The predicted secondary structural elements and RCI-S2 values (black lines; decreasing values from 1 to
0 indicate increasing flexibility), calculated with the MICS algorithm, are plotted for the PNT domains in their monomeric and complexed states. Missing
data correspond to residues lacking chemical shift assignments. The locations of the four α-helices (H1-H4) observed in the X-ray crystal structures of the
ETV6 PNT domain are indicated as rectangles above each plot. RCI-S2, random coil index-squared order parameter; MICS, motif identification from chemical
shift.
Characterizing the ETV6 PNT domainchanges upon mutation or association into the structures
previously characterized by X-ray crystallography.
Armed with chemical shift assignments, the amide 1HN-15N
CSPs resulting from PNT domain dimerization were readily
calculated. Of note, residues in the 15N-labeled A93D-PNT
and V112E-PNT domains that experienced the greatest spec-
tral perturbations cluster within the EH- and ML-surfaces,
respectively (Fig. 2). This confirms that, as seen by X-ray
crystallography, the two monomerized PNT domains indeed
associate in solution through their wild-type interfaces.
Crystallographic comparison of monomeric and dimeric PNT
domains
In their original studies, the Bowie group obtained crystals
of the V112E-PNT domain (PDB: 1JI7, C2 space group, three
monomers in the asymmetric unit) (13). Despite burial ofE112, the monomers assembled in the crystal lattice via their
ML- and EH-surfaces to form an extended helical polymer
with an approximate 65 screw symmetry (Fig. 3A). Subse-
quently, they determined the structure of a heterodimer
composed of a A93D-PNT domain bound to a V112R-PNT
domain via their complementary wild-type interfaces (PDB:
1LKY, P1 space group, 3 heterodimers in the asymmetric unit)
(5). Although no longer polymeric within the crystal lattice, a
model built from PDB: 1LKY using appropriate monomers
subunits with native interfaces closely matched the polymeric
structure of PDB: 1JI7 with the V112 E substitution. Thus, the
latter serves as a reliable experimental structure of the ETV6
PNT domain polymer.
The NMR spectroscopic studies presented above indicate
that the secondary structures and binding interfaces of the
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Figure 2. PNT domain dimerization interface identified by amide
chemical shift perturbations. A, Backbone amide 1HN-15N CSPs resulting
from the heterodimerization of the V112E-PNT (top) and A93D-PNT (bottom)
domains. Missing data correspond to prolines or residues without assigned
NMR signals in both protein states. Most residues showed small CSPs which
may be due in part to the different conditions under which spectra were
assigned (V112E-PNT domain monomer, pH 8.0; V112E-PNT domain com-
plexed with the A93D-PNT domain, pH 7.5; A93D-PNT domain monomer,
pH 7.0; A93D-PNT domain complexed with the V112E-PNT domain, pH 7.0).
B, However, amides with CSP values >0.2 ppm, which are highlighted in
orange on a model of the V112E- (green)/A93D- (blue) PNT domain heter-
odimer, map to the interfacial regions. The cartoon is derived from PDB:



























Figure 3. Structural comparison of the monomeric and polymeric ETV6
PNT domain variants. A, The X-ray crystallographic structure of the V112E-
PNT domain from PDB: 1JI7. The three subunits of the V112E-PNT domain in
the asymmetric unit (green) form a helical polymer with neighboring sub-
units (gray). The mutated E112 side chain (EH-surface) is shown as red
spheres and the wild-type A93 (ML-surface) as blue spheres. B, The structure
of the A93D-V112E-PNT domain determined herein. The two A93D-V112E-
PNT domains in the asymmetric unit are highlighted in orange (E112 as
red spheres, D93 as purple spheres), and neighboring asymmetric units are
in gray. The crystal contacts are unlike those in the polymeric structure and
do not involve the ML- or EH-surfaces. C, Structural overlay of an A93D-PNT
domain subunit that was in complex with a V112R-PNT domain (blue, PDB:
1LKY chain B) and the A93D-V112E-PNT domain (orange), determined
herein. Residues at positions 93 and 112 are highlighted. In contrast to well-
aligned interior side chains, variations in the rotamer conformations of
surface side chains and the N-terminal residues can be seen.
Characterizing the ETV6 PNT domainresemble those observed by X-ray crystallography. However,
the PNT domain in a complexed form may have subtle
structural differences relative to a monomeric form. To
examine this possibility, a variant with both A93D and V112 E
mutations was generated and found to crystallize in 2.8 M
sodium acetate at pH 7.0. Its structure was solved to 1.86 Å
resolution using molecular replacement (Table S2). The
A93D-V112E-PNT domain crystallized in the space group
P6522 with two monomers in the asymmetric unit (Fig. 3B).
Most importantly, the presence of both monomerizing muta-
tions prevented any intermonomer interactions within the
crystal lattice via the ML- and EH-surfaces. Rather, nearest
neighbor contacts were via alternative interfaces that are not
relevant to polymerization of the wild-type PNT domain.
Regardless of differing crystallization conditions and muta-
tions, the structure of the A93D-V112E-PNT domain closely4 J. Biol. Chem. (2021) 296 100284resembles those previously determined for other ETV6 PNT
domain variants. Using the DALI server to compare one
subunit from this structure with a A93D-PNT domain subunit
from PBD entry 1LKY, a total of 77 residues were aligned with
a root mean squared deviation (RMSD) value of 0.7 Å and
Z-score of 16.8 (26). However, a few subtle differences can be
seen upon detailed comparison (Fig. 3C). For example, resi-
dues N-terminal to helix H1 have variable conformations. This
is consistent with their RCI-S2 scores indicating a degree of
flexibility (Fig. 1C). Not unexpectedly, several surface residues
adopted different side chain rotamer conformations, whereas
residues within the interior hydrophobic core of the
PNT domain superimposed well. Most importantly, the
local structural features of the ML- (including residue 93) and
Characterizing the ETV6 PNT domainEH- (including residue 112) surfaces do not differ despite the
presence or absence of monomerizing mutations or their
association upon heterodimer or polymer formation. Thus,
interactions of the ETV6 PNT domain do not contribute to
any discernible conformational changes between its mono-
meric, heterodimeric, or polymeric forms.
Amide hydrogen exchange data show increased protection of
interfacial residues upon dimerization
Amide HX is a useful technique to characterize protein
structure, stability, and dynamics, as well as identifying ligand-
binding interfaces (27–29). Through a continuum of local to
global conformational fluctuations, main chain amide hydro-
gens are constantly exchanging with the hydrogens of solvent
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Figure 4. PNT domain amide HX protection factors increase upon hetero
complexed (right) forms of the A93D-PNT domain in H2O (blue) and after 3 day
were protected from HX. A summary of the protection factors (PFs) for the (B)
states (values in Table S3). Missing data correspond to prolines, residues with u
before collection of the first 15N-HSQC spectrum after transfer into D2O buffer
latter include amides preceding residue 60, which were not observed for any p
exchanged significantly after 3 months, estimated lower limits of log(PF) values
D, A comparison of the amide PFs of the V112 E PNT-domain and A93D-PNT d
are located near the complementary wild-type ML- (containing A93) and EH- (co
regions are indicated with rectangles. HX, hydrogen exchange; HSQC, heteronwill become silent for 1H-detected NMR, and thus, its signal
will disappear from an 15N-HSQC spectrum. The rate at which
it disappears is determined by its structural features (e.g.,
hydrogen bonding and solvent accessibility), as well as the
experimental conditions (e.g., pH and temperature). To ac-
count for the latter, the observed exchange rate constant can
be compared with the predicted rate constant for a random
coil polypeptide with the same sequence and under the same
conditions. The ratio of the predicted versus observed rate
constants is the protection factor (PF).
To gain further insights into the ETV6 PNT domain dy-
namics, NMR spectroscopy was used to measure the amide
PFs of its monomeric and heterodimeric forms. By
comparing the spectra recorded after 3 days of exchange
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dimerization. A, Overlaid 15N-HSQC spectra for the monomeric (left) and
s at 21oC in D2O buffer (orange). More amides in the heterodimeric species
A93D-PNT and (C) V112E-PNT domains in their monomeric and complexed
nassigned or overlapping amide chemical shifts, or residues that exchanged
and thus have log(PF) values less than an estimated upper limit of 3. The
rotein after transfer into D2O buffer. In the cases of amides with that had not
>7 (monomeric) and >8.5 (heterodimeric) are indicated by upwards arrows.
omains when associated within a heterodimer. The most protected amides
ntaining V112) interfaces of the two species, respectively (Fig. 5). The helical
uclear single quantum coherence.
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Characterizing the ETV6 PNT domainprotected from HX in the heterodimeric versus monomeric
species. Exchange rate constants for most amides were
determined by fitting their time-dependent 1HN-15N signal
intensities to single exponential decays. These values were
converted into the PFs summarized in Figure 4, B and C and
tabulated in Table S3.
The monomeric A93D-PNT and V112E-PNT domains
exhibited very similar patterns of amide HX. All residues N-
terminal to Y60 and most of those in interhelical regions
exchanged rapidly under these experimental conditions. This
is consistent with their surface exposure and general lack of
intramolecular hydrogen bonding interactions (Table S3).
Conformational flexibility of these residues was also indicated
by their RCI-S2 values (Fig. 1C). Conversely, amides within or
near the four α-helices showed substantial protection from
HX. In particular, W69 and L70 in helix H1 and L116 and
L117 in helix H4 of both proteins exchanged very
slowly, with several of these residues having log(PF) values
>7. Under the commonly observed EX2 conditions, with
pH-dependent bimolecular kinetics, PFs reflect the residue-
specific free energy changes, ΔGHX = 2.303RTlog(PF), gov-
erning local or global conformational equilibria leading to
exchange (31). Assuming that these most protected amides
exchange through global or near-global structural fluctua-
tions, these HX data provide an estimation of the unfolding
free energy for each monomeric PNT domain of >40 kJ/mol.
Such a value is consistent with the view that, even without
polymerizing, the ETV6 PNT domain adopts a very stable
folded conformation. This further indicates that the A93D
and V112 E mutations prevent polymerization without
disrupting the structure or stability of the monomeric PNT
domain.
Heterodimerization resulted in increased HX protection for
many residues in both the A93D-PNT and V112E-PNT do-
mains (Fig. 4, B and C). Indeed, several amides in both proteins
did not exchange significantly even after 3 months in D2O
buffer and thus have log(PF) > 8.5 (and ΔGHX > 48 kJ/mol).
Although global stabilization upon heterodimer formation is
expected, many of the residues with at least a 100-fold increase
in HX protection localized around the complementary
interfacial regions of the two PNT domains (Figs. 4D and 5, A
and B). These are exemplified by amides within or near the
wild-type ML-surface of the V112E-PNT domain (N90, K92,
A93, L96, T98, D101, F102) and the wild-type EH-surface of
the A93D-PNT domain (F77, V112, L113, Y114). Given that
the structures of the A93D-PNT and V112E-PNT domains do
not change significantly upon heterodimerization, the
increased protection of interfacial residues against HX may
result from their local stabilization against conformational
fluctuations allowing exchange. Alternatively, if exchange oc-
curs predominantly through transient monomers, then the
increased protection of amides in the heterodimer would
reflect the equilibrium population distribution of these two
species (27). Regardless of mechanism, the HX data are
consistent with the role of these interfaces in ETV6 PNT
domain polymerization.6 J. Biol. Chem. (2021) 296 100284Alanine scanning mutagenesis at the PNT domain self-
association interface
Alanine scanning mutagenesis was used to identify which
residues at the PNT domain heterodimer interface
contribute most to binding affinity. The mutation of a res-
idue to alanine reduces its side chain to a single methyl
group, thereby eliminating its contributions to intermolec-
ular binding, while also avoiding the introduction of any
additional non-native interactions. Alanine was chosen over
glycine as the latter may lead to increased backbone flexi-
bility. For these studies, surface plasmon resonance (SPR)
was used to characterize the binding interaction as this
technique is rapid and uses only small quantities of bacte-
rially expressed proteins.
Initial controls were performed to reproduce the results of
previously reported SPR studies of the PNT domain dimer-
ization (13). Either the biotinylated A93D-PNT or V112E-PNT
domain was immobilized on a streptavidin chip, and the
complementary (positive control) or same (negative control)
PNT domain was applied as the analyte at various concen-
trations (Fig. S7). High affinity binding was seen for the het-
erodimer pairings, whereas the identical PNT domains did not
measurably interact. The A93D-PNT domain analyte bound
the V112E-PNT domain ligand with a fit KD value of 7.5 nM,
and the V112E-PNT domain analyte bound the A93D-PNT
domain ligand with a fit KD value of 5.1 nM. These results
agreed well with previously reported KD values of 1.7 to 4.4 nM
for the PNT domain interactions as measured by SPR (13) and
isothermal titration calorimetry (19). Thus, SPR was used to
characterize the effects of alanine substitutions of 18 residues
within or around the EH-surface of the A93D-PNT domain
and 14 residues within or around the ML-surface of the
V112E-PNT domain (Tables 1 and 2).
Six out of 18 on the A93D-PNT domain and seven out of 14
tested residues on the V112E-PNT domain had large detri-
mental effects on binding (ΔΔG >6 kJ/mol) and can be clas-
sified as hot spots (Fig. 6A). Although more difficult to
interpret than KD values, these mutations acted to varying
degrees by slowing the association rate constants, kon, and/or
increasing the dissociation rate constants, koff. The higher
proportion of hotspot interfacial residues on the V112E-PNT
domain, including the three most detrimental of the entire
set of alanine mutants, suggests that the features of this
interface contribute most significantly to PNT domain
polymerization.
Many of the hydrophobic residues at the center of the
heterodimer interfaces are hotspots for binding. In particular,
the L96 A mutation on the ML-surface of the V112E-PNT
domain resulted in an 1000-fold decrease in affinity. As
shown in Figure 6B, L96 protrudes out of the V112E-PNT
domain as a “bump” to fit into the “hole” between residues
F77, V112, E115, and H119 on the EH-surface of the A93D-
PNT domain. Thus, in addition to contributing to hetero-
dimerization through the hydrophobic effect, L96 partakes in
favorable van der Waals interactions at the protein–protein
interface. Other hydrophobic residues that are important
V112E-PNT (Complexed) A93D-PNT (Complexed) 
PF > 900 PF > 10,000 PF > 1,000,000 PF > 100,000,000













































Figure 5. Mapping of HX protection factors on the monomeric and complexed PNT domain structures. Amide protection factors (PFs) are encoded as
spheres on the ribbon diagrams (from PDB: 1LKY) of the V112E-PNT (green) and A93D-PNT (blue) domains in their (A) monomeric and (B) heterodimeric
forms according to the indicated color and size scheme. Residues without spheres are either prolines, lack an assigned or fully resolved 1HN-15N signal, or
exchanged too fast for reliable HX quantitation. Both monomeric PNT domains showed similar HX profiles, with the most protected amides located in
structured helical regions. Upon association, the PFs of many amides at the complementary dimer interfaces increased. HX, hydrogen exchange.
Characterizing the ETV6 PNT domaininclude L97 and M89 on the ML-surface and F77, L79, and
V112 on the EH-surface.
Surrounding the hydrophobic center of the heterodimer
interface is a ring of residues that generally have moderate
contributions toward binding affinity (Figure 6B). However, an
important exception is the peripheral K99 on the A93D-PNT
domain EH-surface. This residue forms an intermolecular salt
bridgewithD101 on theML-surface of theV112E-PNTdomain.
Alaninemutations of K99 orD101 resulted in decreased binding
affinities of 930 nM or 400 nM, respectively. Thus, consistent
with their salt bridge pairing, either mutation weakened binding
relative to thewild-type by a factor of100.Mutation of K99 has
been shown to interfere with EN oncogenic cellular trans-
formation, confirming the functional importance of this salt
bridge (19). A second intermolecular salt bridge consistently
seen in the PNT domain heterodimer structures involves R105-
D111. The R105 A and D111 A mutations also severely weak-
ened binding to KD values of 2.3 μM and 400 nM, respectively,
thus confirming the importance of this interaction. In contrast,several additional salt bridges involving K99-E100, R103-E100,
and R103-D101 are seen in some, but not all crystallographically
defined interfaces. However, alanine substitutions of either E100
or R103 did not significantly impact binding. Thus, the K99-
D101 and R105-D111 salt bridges play important roles in PNT
domain association, whereas those involving E100 or R103 do
not. It is also notable that the polar residue N90 on the ML-
surface of the V112E-PNT domain surface is also a hotspot,
but it does not appear to have a potential reciprocal hydrogen
bond donor or acceptor. Overall, the alanine scanning muta-
genesis study illustrated that PNT domain dimerization is a
result of interactions involving both hydrophobic and charged
interfacial residues.
Molecular dynamics simulations of the PNT monomer and
dimer
MD simulations were run on the A93D-V112E-
PNT domain monomer, reported herein, and the PNT
domain heterodimer, comprising an A93D-PNT domain andJ. Biol. Chem. (2021) 296 100284 7
Table 1
Alanine scanning mutagenesis of the EH-surface on the A93D-PNT domaina
Ala mutation kon (M
−1 s−1) koff (s
−1) KD (nM) ΔΔG (kJ/mol)
b
None (2.0 ± 0.03) × 105 (1.5 ± 0.01) × 10−3 7.5 ± 0.10
S47A (2.1 ± 0.02) × 105 (1.4 ± 0.01) × 10−3 6.9 ± 0.09 −0.2 ± 0.05
I48A (3.4 ± 0.03) × 105 (4.0 ± 0.03) × 10−3 12 ± 0.15 1.2 ± 0.05
E76A (6.2 ± 0.10) × 105 (6.2 ± 0.08) × 10−3 9.9 ± 0.20 0.7 ± 0.06
F77A (3.4 ± 0.11) × 104 (1.5 ± 0.04) × 10−2 450 ± 21 10.2 ± 0.12
S78A (2.8 ± 0.58) × 106 (9.3 ± 1.8) × 10−3 3.3 ± 0.96 −2.0 ± 0.71
L79A (8.1 ± 0.10) × 103 (1.6 ± 0.03) × 10−3 200 ± 4 8.2 ± 0.06
R80A (9.1 ± 0.11) × 104 (2.9 ± 0.02) × 10−3 32 ± 0.4 3.6 ± 0.05
K99A (2.4 ± 0.02) × 103 (2.3 ± 0.01) × 10−3 930 ± 9 12.0 ± 0.04
E100A (3.1 ± 0.02) × 105 (1.5 ± 0.01) × 10−3 5 ± 0.04 −1.0 ± 0.04
R103A (2.5 ± 0.27) × 105 (5.4 ± 0.48) × 10−3 21 ± 3 2.6 ± 0.35
P107A (2.6 ± 0.03) × 105 (2.1 ± 0.01) × 10−3 8.1 ± 0.10 0.2 ± 0.05
H108A (2.6 ± 0.02) × 105 (1.4 ± 0.005) × 10−3 5.4 ± 0.04 −0.8 ± 0.04
D111A (3.3 ± 0.04) × 103 (1.4 ± 0.02) × 10−3 420 ± 8 9.9 ± 0.06
V112A (2.0 ± 0.06) × 104 (1.1 ± 0.02) × 10−2 550 ± 19 10.7 ± 0.09
Y114A (3.5 ± 0.04) × 104 (4.5 ± 0.03) × 10−3 130 ± 2 7.1 ± 0.05
E115A (2.3 ± 0.08) × 105 (2.5 ± 0.06) × 10−3 11 ± 0.5 1.0 ± 0.12
L116A (2.3 ± 0.004) × 105 (7.6 ± 0.02) × 10−4 3.3 ± 0.01 −2.0 ± 0.04
H119A (2.7 ± 0.02) × 105 (3.4 ± 0.02) × 10−3 13 ± 0.12 1.4 ± 0.04
SPR, surface plasmon resonance.
a All A93D-PNT domain analytes were run on the streptavidin SPR chip bound with the biotinylated V112E-PNT domain ligand. Tabulated are fit values of kon and koff with
standard errors, and derived values of KD and ΔΔG with propagated errors.
b Calculated as ΔΔG = RT ln(KD,mutant/KD,wild-type) where wild-type is the top-listed protein with an unmodified interface.
Characterizing the ETV6 PNT domainV112R-PNT domain from PBD: 1LKY. Both the monomer and
the heterodimer remained structurally stable throughout the 1
μs simulations with no drift in the RMSDs of backbone atoms
after equilibration (Fig. 7A). Importantly, the PNT domain
subunits remained associated with each other, indicating that
the heterodimer can be modeled in silico. The transition
occurring around 150 ns in the monomer trajectory corre-
sponds to a rearrangement of its N-terminal residues. Indeed,
the RMSD values of these ETV6 truncations (residues 47–123)
are dominated by motions of their termini. Restricting the
analyses to residues 57 to 120 reduced the backbone RMSD
values to 1 Å. This further demonstrates that, regardless of
mutation or association state, the PNT domain core helical
bundle is relatively rigid.
Plots of the all-atom root mean squared fluctuations
(RMSFs) of each residue over the trajectories are similar for
the monomeric and heterodimeric PNT domains, again
showing low mobility in the core and higher mobility at theTable 2
Alanine scanning mutagenesis of the ML-surface on the V112E-PNT do
Ala mutation kon (M
−1 s−1) koff
None (4.4 ± 0.09) × 105 (2.3 ± 0.
I59A (4.3 ± 0.03) × 105 (2.5 ± 0.
R63A (3.6 ± 0.04) × 105 (5.4 ± 0.
N85A (3.5 ± 0.04) × 105 (3.4 ± 0.
E88A (5.0 ± 0.03) × 105 (4.0 ± 0.
M89A (9.7 ± 0.16) × 104 (3.3 ± 0.
N90A (7.8 ± 0.20) × 104 (3.7 ± 0.
K92A (3.5 ± 0.06) × 105 (2.2 ± 0.
L96A (9.5 ± 1.3) × 103 (9.5 ± 1.
L97A (9.8 ± 0.16) × 104 (6.8 ± 0.
T98A (6.2 ± 0.05) × 105 (5.4 ± 0.
E100A (5.0 ± 0.04) × 105 (3.5 ± 0.
D101A (6.3 ± 0.12) × 103 (2.5 ± 0.
Y104A (7.3 ± 0.10) × 105 (1.5 ± 0.
R105A (2.3 ± 0.11) × 103 (5.4 ± 0.
SPR, surface plasmon resonance.
a All V112E-PNT domain analytes were run on the streptavidin SPR chip bound with th
standard errors, and derived values of KD and ΔΔG with propagated errors.
b Calculated as ΔΔG = RT ln(KD,mutant/KD,wild-type) where wild-type is the top-listed prote
8 J. Biol. Chem. (2021) 296 100284termini (Fig. 7B). This is consistent with the RCI-S2 values
presented in Figure 1C. Principal component analysis of the
trajectories was also performed to explore low frequency
conformational motions. In each case, the proportion of the
motion (variance) was largely confined to the first few prin-
cipal components (Fig. S8). Inspection of the first two principal
components (Videos S1–S4) shows that these motions in both
the monomeric and heterodimeric PNT domains mostly
comprise random conformational changes of their N- and C-
terminal segments.
A closer look at the data presented in Figure 7B shows that
the RMSF values of residues near the termini of the A93D-
PNT domain in the heterodimer are lower than those of
both its V112R-PNT domain partner and the monomeric
A93D-V112E-PNT domain. This can be better seen in a plot of
the difference in RMSF values between corresponding residues
in the two components of the heterodimer (Fig. 7C). When
mapped onto the structure of the heterodimer, residues withmaina
(s−1) KD (nM) ΔΔG (kJ/mol)
b
03) × 10−3 5.1 ± 0.13
01) × 10−3 5.8 ± 0.05 0.3 ± 0.06
05) × 10−3 15 ± 0.2 2.7 ± 0.07
03) × 10−3 9.9 ± 0.13 1.6 ± 0.07
02) × 10−3 8.1 ± 0.07 1.1 ± 0.06
03) × 10−2 340 ± 6 10.4 ± 0.08
10) × 10−2 480 ± 17 11.3 ± 0.11
04) × 10−2 62 ± 1.6 6.2 ± 0.09
1) × 10−3 1000 ± 180 13.1 ± 0.45
06) × 10−2 700 ± 13 12.2 ± 0.08
04) × 10−3 8.8 ± 0.09 1.3 ± 0.07
02) × 10−3 7 ± 0.07 0.8 ± 0.07
04) × 10−3 400 ± 10 10.8 ± 0.09
02) × 10−2 21 ± 0.37 3.5 ± 0.08
11) × 10−3 2340 ± 120 15.2 ± 0.14
e biotinylated A93D-PNT domain ligand. Tabulated are fit values of kon and koff with
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Figure 6. Characterization of the PNT domain interface by alanine scanning mutagenesis. A, A summary of the effects of alanine substitutions on the
ML-surface of V112E-PNT domain (top) and the EH-surface of the A93D-PNT domain (bottom). Each ΔΔG value corresponds to the change in binding free
energy to the complementary PNT domain relative to that of the reference protein with an unmodified wild-type interface (Tables 1 and 2). Standard errors
are shown by the black lines. B, The effects of alanine substitutions on the KD values for heterodimer dissociation are mapped onto the structures of the
V112E- (green background) and A93D- (blue background) PNT domains. Residues for which alanine mutations maintained binding affinity approximately the
wild-type KD (10−9 M) are indicated in pale yellow, whereas those weakening binding by approximately 10-fold (orange), 100-fold (red) and 1000-fold
(burgundy) are in increasingly darker colors.
Characterizing the ETV6 PNT domainthe largest ΔRMSD values clustered near the interface
(Fig. 7D). That is, over the course of the MD simulations,
residues near or at the wild-type ML-surface of the V112R-
PNT domain exhibited smaller fluctuations than the corre-
sponding residues of the mutated unbound ML-surface of the
A93D-PNT domain. Similarly, residues near or at the wild-
type EH-surface of the A93D-PNT domain, which includes
its termini, exhibited smaller fluctuations than the corre-
sponding residues of the mutated EH-surface of the V112R-
PNT domain. Thus, although overall relatively rigid in MD
simulations, to some degree heterodimerization reduced the
mobility of residues at the bound interfacial regions of the
heterodimeric PNT domains.
We also explored whether the dynamics simulations could
be correlated with the experimental HX PFs. Despite time
scales differing by many orders of magnitude, such a cor-
relation between hydrogen bond persistence in MDsimulations with PFs, measured with NMR spectroscopy,
was observed in a short helical peptide (32). Presumably, the
persistence of hydrogen bonding reflects the underlying
rigidity of the structure responsible for damping conforma-
tional motions required for exchange. Hence, the two
backbone carbonyl oxygens closest to every amide nitrogen
in the proteins were selected as candidates for backbone
hydrogen bonding. The averages of these distances were
calculated over the trajectories and amides nitrogens within
3.5 Å to carbonyl oxygens were assigned as being hydrogen
bonded. As summarized in Figure S9, most of these amides,
which are located in α-helices, exhibited measurable pro-
tection from HX (i.e., with log(PF) > 3). However, several
additional hydrogen-bonded amides in loop regions or the
N-terminal segments of the PNT domain constructs
exchanged more rapidly, with log(PF) values less than an
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Figure 7. Analysis of PNT domain structural fluctuations from MD simulations. A, The RMSD values of the backbone atoms of residues 47 to 123
throughout the 1 μs MD simulation are plotted relative to the starting structures at 0 ns. After the initial equilibration, both the monomer (A93D-V112E-PNT
domain) and heterodimer complex (A93D-PNT and V112R-PNT domains) showed little conformational drift. The event around 150 ns in the monomer
simulation corresponds to a rearrangement of the N-terminal residues. The lower darker lines in both graphs correspond to the same analysis for the core
residues 57 to 120 with the flexible N-terminal (47–56) and C-terminal (121–123) segments omitted. The low and consistent RMSD values 1 Å across the
trajectories indicate the rigidity of the core PNT domain. B, The RMSF values of all atoms in each residue along the simulation trajectory are plotted for the
monomer and heterodimer. The left plot shows the A93D-V112E-PNT monomer (orange) and the right plot shows both the V112R-PNT domain (green) and
A93D-PNT domain (blue) in the heterodimer. In the heterodimer, the termini of the A93D-PNT domain, which are close to the interface, have lower mobility
than those of the partner V112R-PNT domain or the monomeric A93D-V112E-PNT domain. C, The graph shows the ΔRMSF values obtained by subtracting
the corresponding RMSF values of the A93D-PNT domain from those of the V112R-PNT domain in the heterodimer complex. Positive values (gold) and
negative values (magenta) correspond to lower fluctuations for residues in the A93D-PNT domain and the V112R-PNT domain, respectively. D, The ΔRMSF
values (>0.3 Å gold, < −0.3 Å magenta) are mapped onto the structure of the V112R- (green)/A93D- (blue) PNT domain heterodimer. Residues with reduced
mobility cluster around the heterodimer interface. RMSF, root mean squared fluctuation; RMSD, root mean squared deviation; MD, molecular dynamics.
Characterizing the ETV6 PNT domainstable α-helices, these regions of the PNT domain undergo
more facile local conformational fluctuations, including
hydrogen bond breakage, and hence have reduced protection
from HX.
Discussion
The ETV6 PNT domain retains a similar structure in
monomeric and heterodimeric states
Our biophysical studies of the ETV6 PNT domain show
that its tertiary structure is very stable in the monomeric
and heterodimeric forms and is not perturbed by the
presence of monomerizing mutations. There are no10 J. Biol. Chem. (2021) 296 100284substantial conformational differences between these species
as seen both by X-ray crystallography and by NMR spec-
troscopy (secondary structural propensities and chemical
shift perturbations). Furthermore, despite differences in
contact surfaces within crystal lattices, the X-ray crystallo-
graphic structure of a monomeric A93D-V112E-PNT
domain closely resembles that of the heterodimers. Simi-
larly, the 1 μs MD simulations did not show any evidence
for large conformational fluctuations and only small changes
in the mobility of interfacial residues upon heterodimer
formation. Thus, the well-characterized ETV6 PNT domain
structure is retained both before and after polymerization. In
Characterizing the ETV6 PNT domainthis respect, the PNT domain can be viewed as a rigid “lego
block”, poised to self-assemble without any requisite change
in shape.
It is noteworthy that upon association of the A93D-PNT
and V112E-PNT domains, amides exhibiting chemical shift
perturbations and substantially increased HX protection
localized to the wild-type ML- and EH-surfaces and not to
the mutated surfaces. This confirms that only the former
participate in heterodimer formation. Furthermore, along
with a lack of any structural differences between the crys-
tallographically characterized variants, this demonstrates that
the “head” and “tail” interaction surfaces of a PNT domain
are not allosterically coupled. Thus, the initial formation of
the wild-type ETV6 PNT homodimer is unlikely to change
the binding affinity of subsequent monomers to a growing
polymer chain.Alanine scanning mutagenesis identifies interfacial hotspot
residues
Detailed SPR-monitored alanine scanning mutagenesis
studies revealed that the ETV6 PNT domains heterodimerize
with high affinity (KD  nM) because of residues partaking in
electrostatic, van der Waals, and hydrophobic interactions.
Although it has been reported that hotspots are generally not
enriched in electrostatic interactions (33), we found the
opposite with residues in two intermolecular salt bridges (K99-
D101 and R105-D111) being critical for high-affinity binding.
Previous studies have shown that a K99 R substitution also
resulted in weaker binding, indicating that both the charge and
amino acid structure are important, at least for one of these
salt bridges (19). In contrast, the E100-R103 salt bridge does
not contribute significantly as alanine substitutions of these
residues did not result in a reduction in binding affinity or the
oncogenic properties of the EN fusion protein (19). The
presence of this salt bridge, and others involving these resi-
dues, varies between the reported ETV6 PNT domain struc-
tures. This also suggests that it is dynamic and not as
persistent as the two formed by K99-D101 and R105-D111.
Indeed, it is noteworthy that essentially all of the hotspot
residues (i.e., ΔΔG >6 kJ/mol), including these charge pairs,
adopt similar well-ordered side chain conformations in all
known X-ray crystallographic structures, regardless of inter-
molecular packing within the crystal lattice. In contrast, resi-
dues less critical for self-association adopt more variable side
chain conformations.
In addition to A93 and V112 (the founding sites for mon-
omerizing mutations), several hydrophobic residues with the
EH- and ML-surfaces are also hotspots for heterodimerization.
In particular, L96 on the ML-surface plays a critical role in
binding as removal of its side chain resulted in 1000-fold
weaker affinity. The leucine makes contacts with several resi-
dues on the reciprocal EH-interface for which alanine sub-
stitutions also reduced the binding affinity, albeit each to a
lesser extent. Targeting a molecule to bind near these EH-
surface residues may exclude L96 and thereby inhibit PNT
polymerization.Many of the hotspot residues have increased protection from
amide HX
Alanine scanning mutagenesis and amide HX experiments
provide complementary insights into the self-association of the
ETV6 PNT domain. That is, alanine scanning reveals the effect
of removing the side chain of a given residue on the affinity for
heterodimer formation, whereas HX experiments show how
dimerization changes the conformational fluctuations of
backbone amide hydrogens leading to exchange with water. In
general, many of the hydrophobic hotspot residues within the
core regions of the EH- and ML-surfaces, including L79, L96,
L97, T98, Y104, V112, Y114, and L116, also exhibited
enhanced HX protection upon heterodimerization. This is
consistent with their burial, and likely dampened dynamics,
within the heterodimer relative to the monomeric species. In
contrast, although partaking in important intermolecular in-
teractions, K99 and R105 underwent fast amide HX in both the
monomeric and heterodimeric PNT domains, whereas their
salt bridge partners D101 and D111 exhibited increased HX
protection. This is also consistent with the location of the
amides of these residues at the periphery of the dimer
interface.
Hotspot residues are conserved among self-associating PNT
domains
Although present in about one-third of ETS family mem-
bers, the only other known self-associating PNT domains are
those of Drosophila Yan (6) and possibly human ETV7 (7–9).
The structure of the Yan PNT domain has been reported
(PDB: 1SV4) and that of ETV7 can be reliably modeled based
on its 60% sequence identity with the ETV6 PNT domain.
Both Yan and ETV7 have ML- and EH-surfaces with physi-
cochemical features very similar to those of ETV6. Moreover,
all ETV6 hotspot residues identified in this study are either
identical or highly similar in the PNT domains of Yan and
ETV7, whereas less critical interfacial residues show more
sequence variability. These conserved residues likely play
central roles in the self-association of all three ETS family PNT
domains.
Small molecule inhibition of PNT domain polymerization
Recently, we developed and implemented a mammalian
cell-based assay, utilizing a protein-fragment complementation
approach with split Gaussia luciferase, and a yeast two-hybrid
assay to screen chemical libraries for potential inhibitors of
ETV6 PNT domain self-association (17). In parallel, virtual
screening using the Bristol University Docking Engine (34) was
performed to identify compounds predicted to bind the ETV6
polymerization interfaces. Although numerous candidate
molecules were tested, none had inhibitory effects in cellular
assays and none bound to the isolated PNT domain. This work
highlighted the difficulty in disrupting with small molecules
the polymerization of the ETV6 PNT domain which occurs
through two relatively large flat interfaces.
Insights into the factors that drive ETV6 PNT domain
polymerization may aid inhibitor design. For example, smallJ. Biol. Chem. (2021) 296 100284 11
Characterizing the ETV6 PNT domainmolecules that bind interaction surfaces near hotspot hydro-
phobic (e.g., L96) or salt-bridging (e.g., K99-D101 or R105-
D111) residues may competitively prevent PNT domains
from self-associating. However, designing or identifying such
small molecules is challenging as the polymerization occurs
with high affinity, and there does not appear to be any struc-
tural differences between the PNT domains in their mono-
meric and heterodimeric states that could be exploited for
potential binding sites. One strategy that could be imple-
mented for screening assays is to utilize an alanine mutant that
weakens binding. This way, it may be easier to identify an
initial compound that inhibits a micromolar affinity interac-
tion, as opposed to the nanomolar interaction of the wild-type
PNT domains. Once discovered, such a lead molecule could be
optimized for higher affinity binding. As previously shown,
mutations of K99 weaken PNT domain polymerization and
alter the oncogenic properties of EN (19). This residue is not at
the center of the heterodimer interface, and the K99 A or
K99 R mutants may be well suited for such a screening
strategy.
Alternatively, from the alanine scanning mutagenesis, we
know which residues are not hotspots and thus tolerant to
modifications. An example of a technique that would benefit
from this acquired knowledge is disulphide tethering where
weakly binding chemical fragments are tethered via an intro-
duced cysteine residue near the protein-protein interaction
interface (35). In principle, one could modify an ETV6 PNT
domain residue, that does not affect binding and is near a hot
spot, to a cysteine for this approach.
Helix “stapling” is another method that has been used to
design molecules that disrupt protein–protein interactions.
The general principle is to covalently stabilize the secondary
structure of residues that normally form a helix along an
interaction surface (36). The PNT domain, a subset of SAM
domains, is a helical bundle, with helix H4 and helices H2 and
H3 forming complementary interaction surfaces. Residues
D111, V112, and Y114 in helix H4 are all hotspots and expe-
rience substantial increases in HX protection upon dimeriza-
tion. Thus, a stapled helical polypeptide or a polypeptide
mimetic encompassing these residues might be sufficient to
prevent polymerization. In contrast, whereas several residues
in H2 and H3 are hotspots, such as D101 and R105, they are
not adjoining as a single helix. A similar methodology has been
used to target the Ship2 and EphA2 SAM-SAM domain in-
teractions, whereby a penta-amino acid motif found in EphA2
binds to the SAM domain of Ship2, albeit with a KD value in
the high micromolar range (37).
As a closing comment, SPR experiments demonstrated
that the lifetime of the PNT domain heterodimer (1/koff) is
10 min. The lifetime of polymeric forms will be longer
since dissociation must occur at multiple interfaces to
completely monomerize. If the dissociation of the PNT
domain polymer is slow in the context of a PNT–PTK
fusion oncoprotein, then a prospective small molecule in-
hibitor that would have the greatest effect may likely need
to act on newly translated PNT–PTK fusion oncoproteins,
before they polymerize.12 J. Biol. Chem. (2021) 296 100284Experimental procedures
PNT domain expression and purification
The DNA construct encoding residues 1 to 125 of human
ETV6 (Genbank Gene ID: 2120), preceded by a thrombin-
cleavable N-terminal His6-affinity tag (Table S1), was initially
cloned into the pET28a vector (Invitrogen) as described (19).
The monomerizing A93D, V112 E, and A93D-V112 E sub-
stitutions were introduced through QuikChange site-directed
mutagenesis (Stratagene). Subsequently, it was recognized
that a thrombin cleavage site is present within the intrinsically
disordered N-terminal region of these constructs (residues
V37-P38-R39↓A40). This is located just before an alternative
start site (M43) for ETV6 expression (14). Thus, ETV6 frag-
ments were expressed from available clones as residues 1 to
125 with a His6-tag and cleaved with thrombin to yield final
purified samples spanning residues 40 to 125.
PNT domain-containing proteins were expressed in
Escherichia coli BL21 (λDE3) cells grown at 37 C to an OD600
 0.6 and induced with 1 mM IPTG overnight. Unlabeled
proteins were produced in lysogeny broth (LB) media, and M9
minimal media was supplemented with either 1 g/L of
15NH4Cl for
15N-labeled proteins or 1 g/L of 15NH4Cl and 3 g/
L 13C6-glucose for
13 C/15N-labeled proteins. In all cases,
35 mg/L kanamycin was included for plasmid selection. After
continued growth at 37 C overnight, the cells were harvested
by centrifugation (Sorvall GSA rotor; 5000 rpm) and frozen
at −80 C. The cell pellet was thawed for purification and
resuspended in denaturing buffer (4 M GdnHCl, 20 mM so-
dium phosphate, 500 mM NaCl, 20 mM imidazole, pH 7.5)
and lysed by sonication on ice. The lysate was then cleared by
centrifugation (Sorvall SS34 rotor; 15,000 rpm), and the
resulting supernatant was passed through either a 0.45 or
0.8 μm pore size filter and loaded onto a 5 ml Ni+2-NTA
HisTrap HP column (GE Healthcare) pre-equilibrated with
binding buffer (20 mM imidazole, 50 mM sodium phosphate,
500 mM NaCl, pH 7.5). After washing with several column
volumes of binding buffer, the protein was eluted using a
120 ml linear gradient of elution buffer (500 mM imidazole,
50 mM sodium phosphate, 400 mM NaCl, pH 7.5).
The collected fractions were analyzed by SDS-PAGE, and
those containing the desired protein were pooled. In general,
the ETV6 fragments eluted as two major peaks off the Ni2+
column. Previous studies demonstrated that proteins from
these fractions had the same masses yet showed small differ-
ences in their 15N-HSQC spectra (38). Despite significant ef-
forts, the origin of these differences was never elucidated. For
consistency, only the fastest eluting peak was collected and
dialyzed overnight at 4 C in thrombin cleavage buffer (20 mM
Tris, 0.15 mM NaCl, 2.5 mM CaCl2, 0.5 mM EDTA, 1 mM
DTT, pH 8.4) with 1 unit of thrombin (Millipore) per 20 ml
of collected fractions. The cleaved protein was separated from
any His6-tagged species by passage through the Ni
+2-NTA
HisTrap HP column and purified further using size-exclusion
chromatography (Superdex S75, GE Healthcare). This also
served to exchange the protein in a buffer optimized for NMR
experiments (noted below). The concentration of each protein
Characterizing the ETV6 PNT domainsample was determined by ultraviolet absorbance at 280 nm
based on its predicted molar absorptivity (39).
General NMR spectroscopy methods
NMR spectra were recorded with cryoprobe-equipped
Bruker Avance III 500, 600, and 850 MHz spectrometers. All
data acquired were processed and analyzed with NMRPipe
(40) and NMRFAM-Sparky (41, 42). Typically, protein samples
were 150 μM to 600 μM in 450 μl of standard buffer (20 mM
MOPS, 50 mM NaCl, and 0.5 mM EDTA) with D2O (5% v/v)
added for signal locking. Unless otherwise noted, experiments
involving the A93D-PNT domain were conducted at pH 7.0,
and those involving the V112E-PNT domain were conducted
at pH 8.0 because of its propensity to self-associate under
lower sample pH conditions. In the case of the heterodimer
species, the unlabeled partner protein was added to its isoto-
pically labeled partner in a 1.1 M excess. The heterodimer
containing an isotopically labeled V112E-PNT domain was
studied at pH 7.5, whereas that containing an isotopically
labeled A93D-PNT domain was studied at pH 7.0.
Spectral assignments and chemical shift analyses
The signals from mainchain 1H, 13C, and 15N nuclei of the
13C/15N-labeled PNT domain constructs were assigned using
standard heteronuclear 1H-13C-15N scalar correlation experi-
ments (43), including HNCACB, HNCO, CBCA(CO)NH,
HNCACO, along with HSQC-NOESY spectra, recorded on a
600 MHz spectrometer at 25 C. Spectra of the monomeric
A93D-PNT domain were assigned manually, whereas those of
the monomeric V112E-PNT domain and the two heterodimer
complexes were automatically interpreted using PINE (44) and
verified manually. The assigned chemical shifts of these four
species have been deposited in the BioMagResBank.
Secondary structure analyses were carried out using the
motif identification from chemical shift online server (23).
Combined CSPs (Δδ) for the 1HN (ΔδH) and
15N (ΔδN) signals
of the corresponding amides in the dimer versus monomer
species were calculated as Δδ = [(ΔδH)
2 + (0.14ΔδN)
2)]1/2 (20).
Amide hydrogen exchange by NMR spectroscopy
Protium–deuterium HX experiments for the PNT domains
in the absence (monomeric) and presence of their unlabeled
partner (heterodimeric) were conducted on a Bruker Avance
600 MHz spectrometer at 21 C (matching ambient room
temperature). The initial pH values were 7.0 for the samples
containing the 15N-labeled A93D-PNT domains and 7.5 for
those containing the 15N-labeled V112E-PNT domain. Initial
reference 15N-HSQC spectra of the proteins in H2O buffer
were recorded. Subsequently a 450 μl aliquot was lyophilized,
resuspended with the same volume of D2O, and immediately
put into the NMR spectrometer to begin data recording within
4 to 7 min. Initially, a series of  5-min 15N-HSQC spectra
were acquired with two scans/free induction decay to char-
acterize amides exchanging on the minutes timescale. Then
20-min 15N-HSQC spectra with eight scans/free induction
decay were collected back-to-back for 3 h, followed by a 20-min spectrum every hour for 24 h, and then intermittent 20-
min spectra over a period up to 3 months. After the first week,
the sample was removed from the spectrometer and stored at
ambient room temperature between recording spectra. Upon
completion of data recording, the pH* (pH meter reading
uncorrected for the deuterium isotope effect) of each sample
was measured as 7.3 (monomeric A93D-PNT domain), 7.6
(monomeric V112E-PNT domain), 7.4 (15N-labeled A93D-
PNT domain in complex with V112E-PNT domain), and 7.5
(15N-labeled V112E-PNT domain in complex with A93D-PNT
domain).
For each amide with measurable signals at times t after
resuspension in D2O, the pseudo-first order exchange rate
constant kobs was obtained by fitting with NMRFAM-Sparky
the 1HN-15N peak intensity It, scaled for number of acquisi-
tions/free induction decay, to the equation for a single expo-
nential decay:
It ¼ I0e−ðkobsÞðtÞ
I0 is the fit initial intensity extrapolated to t = 0. The protection
factor (PF ¼ kpredkobs ) for each amide was determined as the ratio of
its predicted intrinsic exchange rate constant (kpred) in an un-
structured polypeptide of the same amino acid sequence versus
its experimentally measured kobs. The kpred values were deter-
mined with the program Sphere (45) which uses reference data
based on poly-DL-alanine and corrected for amino acid type,
temperature, pH and isotope effects (46, 47). In the cases of
amide that had not exchanged significantly after 3 months, lower
limits on their PFs were estimated based on the largest measured
PFs for the given sample.
Site-directed mutagenesis and construct cloning
To enable site-directed biotinylation during protein
expression in E. coli, a gene encoding residues 43 to 135 of
V112E ETV6 with an N-terminal His6-tag and Avitag (Table
S1) was constructed in the pET28a vector using polymerase
incomplete primer extension cloning techniques (48, 49). The
A93D and E112V mutations were sequentially introduced to
generate the complementary A93D-PNT domain construct
with the His6-tag and Avitag.
Interfacial residues present in the X-ray crystal structure of
the PNT domain dimer (PDB: 1LKY) were identified using the
online Solvent accessibility-based Protein-Protein Interface
iDEntification and Recognition server [SPPIDER (50)]. Alanine
substitutions were encoded at these sites in the respective
A93D- or V112E-PNT domain clones using QuikChange site-
directed mutagenesis techniques. All but two constructs were
successfully generated in-house, and genes encoding N90A-
V112E-PNT domain and L116A-A93D-PNT domain were
purchased commercially (Biomatik).
Protein expression and purification for surface plasmon
resonance
Each plasmid encoding either the biotinylated A93D-PNT
and V112E-PNT domain was co-transformed into E. coliJ. Biol. Chem. (2021) 296 100284 13
Characterizing the ETV6 PNT domainBL21 (λDE3) with the pET21a-BirA plasmid, which produces
biotin ligase. Selection of both plasmids was maintained by
including kanamycin (35 mg/L) and ampicillin (100 mg/L) in
all media. Overnight seed cultures were used to inoculate LB
media, supplemented with 0.05 mM biotin, and grown at 37 C
to an OD600  0.6. Protein expression was induced with
0.5 mM IPTG, and the cells were grown at 30 C overnight.
The cells were collected by centrifugation and cell pellets were
frozen at −80 C.
Protein purification was carried out fully as described above
with minor modifications. The final size exclusion purification
step was omitted after thrombin cleavage and removal of the
His6-tag by passage through a Ni
+2-NTA HisTrap HP column.
The final protein samples were exchanged into 20 mM MOPS,
50 mM NaCl, 0.5 mM EDTA buffer, at pH 8.0, and concen-
trated to 1 ml with an Amicon 3K MWCO centrifugal filter.
The protein samples were then snap frozen in liquid nitrogen
and stored at −80 C before SPR analysis. The proteins were
50 to 95% biotinylated as judged by MALDI-ToF mass
spectrometry.
Surface plasmon resonance
SPR experiments were performed at 25 C on a Biacore
X100 instrument using the streptavidin Sensor Chip SA to
capture the biotinylated PNT domain “ligand”. The ligand was
diluted to 50 μg/ml in HBS-EP+ buffer (10 mM HEPES,
150 mM NaCl, 3 mM EDTA, 0.05% v/v Tween-20, pH 7.4) and
immobilized on the chip using the Biacore X100 control
software immobilization wizard. The regeneration scouting
software wizard was used to determine the regeneration step
involving flowing 0.2% SDS over the chip for 30 s.
The association (kon) and dissociation (koff) rate constants and
the equilibrium dissociation constant (KD) for binding of the
analyte with the immobilized ligand were determined using the
Biacore X100 kinetics/affinity assay software wizard. The positive
and negative binding controls were analytes with the comple-
mentary wild-type PNT domain interface or with the same
monomerizing substitution, respectively. For the experimental
runs, the analyte protein sample was initially diluted in HBS-EP+
buffer to 0.2, 2, 20, 40, and 60 nM. If weakened binding (KD >
60 nM) was observed, the analyte protein sample was re-run in
HBS-EP+ buffer at 20, 200, 2000, 4000, and 6000 nM.
Structural determination of A93D-V112E-PNT domain by X-ray
crystallography
A construct of ETV6 spanning residues 40 to 125 with the
A93D and V112 E substitutions (A93D-V112E-PNT domain)
was purified as described above. Crystals were grown by sitting
drop vapor diffusion at room temperature with 2 μl drops
prepared with a 1:1 mixture of 9.3 mg/ml protein (20 mM
MOPS, 50 mM NaCl, and 0.5 mM EDTA, pH 7.0) and
reservoir solutions from the Hampton Index reagent crystal-
lization screen (Hampton Research). Several conditions yiel-
ded protein crystals and those grown in 2.8 M sodium
acetate (pH 7.0) were used for data collection. These crystals
were cryoprotected by brief soaking in reservoir buffer14 J. Biol. Chem. (2021) 296 100284supplemented with 30% (v/v) glycerol, followed by flash
freezing in liquid nitrogen.
Diffraction data were collected at the CLS (Canadian Light
Source) on beamline 08B1-1 (51). The data were cut-off at
1.85 Å based on the CC1/2 metric and processed and scaled
using XDS (52). Crystals were of space group P6522 with two
protein molecules in the asymmetric unit. Phase determination
using molecular replacement was performed with a PNT
domain monomer from PDB: 1LKY using the AutoSol pro-
gram in Phenix (53). Model building was performed in Coot,
and refinement was executed using the Phenix software suite
(54). Eight of 85 amino acid residues of the construct (4 at the
N-terminus and 2 at the C-terminus) were disordered in the
crystal and not modeled.
Molecular dynamics simulations on monomeric and
heterodimeric PNT domains
MD simulations were based on coordinate files, encom-
passing residues S47 to Q123, from the crystal structure of the
monomeric A93D-V112E-PNT domain (determined herein)
and a dimer of the A93D-PNT domain and V112R-PNT
domain from PDB: 1LKY.
The MD simulations were performed on the University of
Bristol High Performance Computer BlueCrystal using
GROMACS (Version 5.1.2) (55). The systems were solvated
with TIP3P waters in an orthorhombic box 2 nm larger than
the longest dimension of the protein. Sodium and chloride
ions were included at 50 mM to emulate experimental con-
ditions, while neutralizing the monomerizing mutations to
have no overall net charge. The amber99sb-ildn forcefield was
used to parameterize the protein simulations (56). Non-
bonded long-range electrostatic interactions were calculated
using the Particle Mesh Ewald method with a 1.2 nm cut-off.
Bonds were constrained using the LINCS algorithm allowing
the use of a 2 fs timestep for the MD integration. The energy of
the system was minimized over 5000 steps of the steepest
descent energy minimization. The system then underwent a
position-restraint simulation over 200 ps where the protein
was restrained to its initial position while heating the system to
310 K and introducing pressure at 1 bar using the Berendsen
barostat (55). The full unconstrained MD simulations were run
over 1 μs with integration step sizes of 2 fs using the leap-frog
algorithm, and trajectory files were recorded every 100 ps. The
temperature was maintained at 310 K using v-rescale modified
Berendsen thermostat and at 1 bar with the Parinello-Rahman
barostat. Trajectories were analyzed and processed, including
principal component analysis, utilizing GROMACS tools. The
simulations were visualized with VMD (57), gnuplot, and
PyMol (58).
Data availability
The X-ray structure (coordinates and structure factor files)
has been submitted to the PDB under accession number 7JU2.
The NMR chemical shifts have been submitted to the BMRB
under accession numbers 50430 (Monomeric V112E-PNT
domain), 50431 (Complexed V112E-PNT domain), 50432
Characterizing the ETV6 PNT domain(Complexed A93D-PNT domain), and 50433 (Monomeric
A93D-PNT domain). All other data described here are avail-
able within the manuscript and supporting information.
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